Collegium Pharmaceutical, Inc.COLLNASDAQ
Loading
Operating Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+16.2%
5Y CAGR+17.4%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
+16.2%/yr
vs +6.8%/yr prior
5Y CAGR
+17.4%/yr
Consistent
Acceleration
+9.4pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
2.2x
Strong expansion
Streak
2 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $276.17M | +33.1% |
| 2024 | $207.45M | +30.3% |
| 2023 | $159.21M | -9.6% |
| 2022 | $176.17M | +32.5% |
| 2021 | $132.99M | +7.6% |
| 2020 | $123.60M | -2.5% |
| 2019 | $126.79M | -6.4% |
| 2018 | $135.42M | +33.6% |
| 2017 | $101.33M | +6.0% |
| 2016 | $95.58M | - |